To include your compound in the COVID-19 Resource Center, submit it here.

Cell Therapeutics proposes private placement of preferred stock

Cell Therapeutics Inc. (NASDAQ:CTIC; Milan:CTIC), Seattle, Wash.
Business: Cancer

Read the full 91 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE